Madeleine Cunningham

InterGenetics, Inc. researches and develops therapeutics for the prevention, diagnostics, and treatment of cancer. Its core research has future application in predicting heart disease, diabetes and in drug therapies and preventative medicine. The company was founded by Eldon R. Jupe, David A. Ralph and Craig D. Shimasaki in 1999 and is headquartered in Oklahoma City, OK.

ZymeTx, Inc is a biotechnology company, which is engaged in the discovery, development and commercialization of products used to diagnose and treat viruses. The company's ViraZme technology focuses on the development of molecules that interacts with an enzyme of specific origin, such as viral, mammalian or bacterial origin. It was founded in 1994 and is headquartered in Oklahoma City, OK.

OU Medicine, Inc. provides healthcare services and support to medical school institutions. It offers adult and children services. The company was founded on February 04, 1998 and is headquartered in Oklahoma City, OK.

LeukoSight, Inc. develops therapeutics to treat autoimmune and inflammatory diseases. Its categories include apnea, Canadian health and care mall, Canadian pharmacy mall, chronic obstructive airway disease and erectile dysfunction. The company was founded by David M. Mosser in 2007 and is headquartered in College Park, MD.

Wilkinson Sword Ltd. manufactures razors and disposables. The company was founded in 1889 and is headquartered in Bucks, the United Kingdom.

Doris Duke Charitable Foundation operates charitable foundation. It is engaged in improving the quality of people's lives through grants supporting the performing arts, wildlife conservation, medical research and the prevention of child maltreatment & through preservation of the cultural & environmental legacy of Doris Duke's properties. The foundation's activities are guided by the will of Doris Duke. The organization was founded in 1996 and is headquartered in New York

Plastomics operates as biotechnology company, which develops chloroplast genetic for next generation of high performing crops. The company was founded by Ralph Bock and Jeff Staub in 2016 and is headquartered in St. Louis, MO.

Impetus Agriculture, LLC is an American company that specializes in growing commercial biotech crops and developing bio pesticide formulations. The company was founded in 2018, and Martha Schlicher has been the CEO of the company since 2020.

Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO.

ield Lab Ireland Management Ltd. is a Venture Capital firm, a subsidiary of The Yield Lab Manager LLC founded in 2014 by Paul Finnerty and Brian L. Clevinger. Yield Lab Ireland Management Ltd. is headquartered in Galway.

The Academy of Science of St. Louis operates as an independent science organization. It facilitates interactions between providers of educational programming and community organizations by providing a website and information listing educational programs, resources, and learning opportunities in subjects relating to science, applied science, mathematics, and engineering. The company was founded by George Engelmann and James B. Eads in 1856 and is headquartered in St. Louis, MO.

Prolog Ventures LLC is a venture capital firm founded in 2000 by Brian Clevinger, Greg Johnson and Ilya Nykin. The firm is headquartered in Clayton, Missouri.

TOMA Biosciences, Inc. develops and provides DNA-based cancer testing technology. The company was founded by Hanlee Ji, Lincoln Nadauld, James M. Ford, and Calvin J. Kuo in 2011 and is headquartered in Foster City, CA.

Neurolutions, Inc. develops revolutionary platform of devices, based on Brain Computer Interface (BCI) technology, which promise to restore function to patients who are disabled as a result of neurological injury. The company was founded by Eric Leuthhardt, Daniel J. Moran, and Gerwin Schalk on October 1, 2008 and is headquartered in St. Louis, MO.

BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri.

Immunovalent Therapeutics, Inc. is a medicine company harnessing microfluidic technology for the treatment of cancer immunotherapy. The company is headquartered in St. Louis, MO.

Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO.

St. Louis Arch Angels provides seed and early stage capital to the startup organizations. Its members mentor and coach, serve on boards, provide contacts, assist with team building, strategic planning and fundraising. The company was founded by Gilbert Bickel in January 2005 and is headquartered in Saint Louis, MO.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO.